Table 1.
Treatment | IC50 Value | |||
---|---|---|---|---|
KG-1a | KG-1 | EoL-1 | U937 | |
Idarubicin (Ida) (ng/mL) | 19.82 ± 1.80 ### | 5.45 ± 0.89 *** | 2.57 ± 0.32 *** | 4.72 ± 2.38 *** |
Doxorubicin (Dox) (μg/mL) | 0.69 ± 0.12 ### | 0.21 ± 0.02 *** | 0.02 ± 0.01 ***,## | 0.08 ± 0.02 ***,# |
Curcumin (Cur) (μg/mL) | 9.19 ± 0.49 # | 7.31 ± 1.45 * | 5.55 ± 0.46 **,# | 3.55 ± 0.54 ***,## |
The significance of mean differences was assessed using one-way ANOVA. * p < 0.05, ** p < 0.01, and *** p < 0.001 compared with KG-1a cells. # p < 0.05, ## p < 0.01, and ### p < 0.001 compared with KG-1 cells.